NCT00016250View on ClinicalTrials.gov

Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal Cancer

PHASE2CompletedINTERVENTIONAL
Timeline

Start Date

December 31, 2000

Primary Completion Date

June 30, 2002

Study Completion Date

June 30, 2002

Conditions
Colorectal Cancer
Interventions
DRUG

MKC-1

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00016250 - Ro 31-7453 in Treating Patients With Recurrent or Refractory Metastatic Colorectal Cancer | Biotech Hunter | Biotech Hunter